Cytodiagnosis of pleural effusions according to The International System for Reporting Serous Fluid Cytopathology: retrospective analysis of oncological dispensary experience

O. Grigoruk
{"title":"Cytodiagnosis of pleural effusions according to The International System for Reporting Serous Fluid Cytopathology: retrospective analysis of oncological dispensary experience","authors":"O. Grigoruk","doi":"10.17816/onco546017","DOIUrl":null,"url":null,"abstract":"BACKGROUND. The International Serous Fluid Cytopathology Reporting System (TISRSFC) was proposed in 2020 to standardize cytological reports and include information on perceived risk of malignancy in reports. It is necessary to analyze the use of TISRSFC to determine the principles of rational practical implementation and possible improvement of this classification. AIMS: to assess the possibility and results of the application of TISRSFC (2020) in the cytodiagnosis of pleural effusions in the organizational technologies and resource provision of a regional oncological dispensary. MATERIALS AND METHODS. An observational, crossover, retrospective, crossover study. A comparative analysis of cytological analyzes of pleural effusion with clinical and anamnestic information, histological, immunohistochemical results of 1507 patients. The microscope slide were prepared by the traditional smear method, as well as by liquid cytology. preparations were stained by Papanicolaou and Pappenheim methods. The immunocytochemical tests were performed if necessary. RESULTS: The following cytological reports corresponding to the TISRSFC categories were formulated: non-diagnostic material (C I) - 11 (0.7%), absence of malignant tumor cells (C II) - 946 (62.8%), atypia of unknown significance (C III) - 61 (4.0%), suspicion of a malignant process (C IV) - 13 (0.9%), malignant process (C V) - 476 (31.6%). There were 37 (7.8%) cases of the primary tumor - mesothelioma, 398 (83.6%) cases of metastatic tumors, including 41 (8.6%) cases of non-epithelial tumors in category C V. Immunocytochemical tests of pleural fluid were performed in 273 (18.1%) cases. Risk of malignancy (ROM) was 9.1% (1/11) for C I; 1.2% (11/946) for C II; 59.0% (36/61) for C III; 84.6% (11/13) for C IV and 100% (476/476) for C V. Cytodiagnosis with immunocytochemistry in unclear cases is characterized by a sensitivity of 92.5%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 88.5%, and an accuracy of 96.6%.","PeriodicalId":509207,"journal":{"name":"Russian Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/onco546017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND. The International Serous Fluid Cytopathology Reporting System (TISRSFC) was proposed in 2020 to standardize cytological reports and include information on perceived risk of malignancy in reports. It is necessary to analyze the use of TISRSFC to determine the principles of rational practical implementation and possible improvement of this classification. AIMS: to assess the possibility and results of the application of TISRSFC (2020) in the cytodiagnosis of pleural effusions in the organizational technologies and resource provision of a regional oncological dispensary. MATERIALS AND METHODS. An observational, crossover, retrospective, crossover study. A comparative analysis of cytological analyzes of pleural effusion with clinical and anamnestic information, histological, immunohistochemical results of 1507 patients. The microscope slide were prepared by the traditional smear method, as well as by liquid cytology. preparations were stained by Papanicolaou and Pappenheim methods. The immunocytochemical tests were performed if necessary. RESULTS: The following cytological reports corresponding to the TISRSFC categories were formulated: non-diagnostic material (C I) - 11 (0.7%), absence of malignant tumor cells (C II) - 946 (62.8%), atypia of unknown significance (C III) - 61 (4.0%), suspicion of a malignant process (C IV) - 13 (0.9%), malignant process (C V) - 476 (31.6%). There were 37 (7.8%) cases of the primary tumor - mesothelioma, 398 (83.6%) cases of metastatic tumors, including 41 (8.6%) cases of non-epithelial tumors in category C V. Immunocytochemical tests of pleural fluid were performed in 273 (18.1%) cases. Risk of malignancy (ROM) was 9.1% (1/11) for C I; 1.2% (11/946) for C II; 59.0% (36/61) for C III; 84.6% (11/13) for C IV and 100% (476/476) for C V. Cytodiagnosis with immunocytochemistry in unclear cases is characterized by a sensitivity of 92.5%, a specificity of 100%, a positive predictive value of 100%, a negative predictive value of 88.5%, and an accuracy of 96.6%.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
根据国际浆液细胞病理学报告系统对胸腔积液进行细胞诊断:对肿瘤诊所经验的回顾性分析
背景。国际浆液细胞病理学报告系统(TISRSFC)于 2020 年提出,旨在规范细胞学报告,并在报告中纳入恶性肿瘤感知风险信息。有必要对 TISRSFC 的使用情况进行分析,以确定合理实用的原则,并对该分类进行可能的改进。 目的:评估 TISRSFC(2020)在胸腔积液细胞诊断中应用的可能性和结果,以及地区肿瘤医院的组织技术和资源提供情况。 材料与方法:一项观察性、交叉、回顾性研究。对 1507 名患者的胸腔积液细胞学分析结果与临床和病理资料、组织学和免疫组化结果进行比较分析。显微载玻片采用传统涂片法和液体细胞学法制备。必要时进行免疫细胞化学检测。 结果:根据 TISRSFC 分类得出了以下细胞学报告:无诊断材料(CⅠ)--11(0.7%),无恶性肿瘤细胞(CⅡ)--946(62.8%),不典型性意义不明(CⅢ)--61(4.0%),怀疑恶性过程(CⅣ)--13(0.9%),恶性过程(CⅤ)--476(31.6%)。有 37 例(7.8%)原发性肿瘤--间皮瘤,398 例(83.6%)转移性肿瘤,包括 41 例(8.6%)C V 类非上皮性肿瘤。273 例(18.1%)胸腔积液进行了免疫细胞化学检测。恶性肿瘤风险(ROM)为:C I 类 9.1%(1/11);C II 类 1.2%(11/946);C III 类 59.0%(36/61);C IV 类 84.6%(11/13);C V 类 100%(476/476)。在不明确的病例中,免疫细胞化学的细胞诊断灵敏度为 92.5%,特异性为 100%,阳性预测值为 100%,阴性预测值为 88.5%,准确率为 96.6%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Diagnosis of metastatic melanoma by fine-needle aspiration biopsy (FNAB) and primary melanoma using the skin and mucousa imprints The problem of pancreatic fistula development after pancreatic surgery in oncological patients The state of cancer care in Russia: epidemiology and survival in patients with the most common and life-threatening solid malignant tumors. Part 1. (Population study) Роль нейтрофилов опухолевого микроокружения в прогрессии люминального HER2-негативного раннего рака молочной железы Immunophenotype of dendritic cell differentiation markers in breast cancer in in vitro conditions
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1